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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYTumorigenic potential of human pluripotent stem cells (hPSCs) is an important issue in clinical applications. Despite many efforts, PSC-
derived neural precursor cells (NPCs) have repeatedly induced tumors in animalmodels even though pluripotent cells were not detected.
We found that polysialic acid-neural cell adhesion molecule (PSA-NCAM) cells among the early NPCs caused tumors, whereas PSA-
NCAM+ cells were nontumorigenic. Molecular profiling, global gene analysis, and multilineage differentiation of PSA-NCAM cells
confirm that they aremultipotent neural crest stem cells (NCSCs) that could differentiate into both ectodermal andmesodermal lineages.
Transplantation of PSA-NCAM cells in a gradient manner mixed with PSA-NCAM+ cells proportionally increased mesodermal tumor
formation and unwanted grafts such as PERIPHERIN+ cells or pigmented cells in the rat brain. Therefore, we suggest that NCSCs are a
critical target for tumor prevention in hPSC-derived NPCs, and removal of PSA-NCAM cells eliminates the tumorigenic potential orig-
inating from NCSCs after transplantation.INTRODUCTION
In a process of attempting to mimic primary neuralization
in vivo, studies have focused their attention on differenti-
ating neural precursor cells (NPCs) from pluripotent
stem cells (PSCs) for basic research and biomedical
applications (Conti and Cattaneo, 2010). Given their
advantages of a long-term expansion, high-culture purity,
long-term neurogenic potentials, and their ability to sur-
vive cryopreservation, NPCs from human (h)PSC-derived
neural rosettes, which represent neuroepithelial cells of
unclosed and closed neural tubes, are an ideal cell source
for biomedical applications (Chambers et al., 2009; Elka-
betz et al., 2008; Koch et al., 2009). Unfortunately, how-
ever, there have been reports of tumor formation after
transplantation even in the absence of undifferentiated
PSCs. Two distinctive types of tumors have been mainly
described: neural overgrowth and mesodermal tumors.
Neural rosettes (early NPCs) possess self-renewing multi-
potent characteristics, and a previous study showed
neural overgrowth when they were transplanted in vivo
(Elkabetz et al., 2008). Subsequent studies overcame this
tumorigenic potential by further committing primitive
NPCs to specific cell types and increasing differentia-
tion efficiency (Kirkeby et al., 2012; Kriks et al., 2011;
Liu et al., 2013). Despite efforts to avoid pluripotent
cell contamination and NPC-neural overgrowth, re-
searchers continue to report tumor formation post-trans-
plantation of human embryonic stem cell (hESC)-derivedStemNPCs or neuronal precursor cells in animal models of CNS
disorders containing chondrocytes, muscle fibers (Arn-
hold et al., 2004), mesoderm-derived mature cartilage
(Seminatore et al., 2010), and pigmented cells (Doi
et al., 2012).
Meanwhile, in vitro studies of neural induction from
hPSCs have suggested that radial arrangements of
columnar neuroepithelial cells, termed neural rosettes,
can differentiate toward peripheral nervous system (PNS)
lineages (Chambers et al., 2009; Kim et al., 2010) and re-
ported evidence of neural crest-like cells within the neural
rosette cultures (Elkabetz et al., 2008; Kim et al., 2012; Lee
et al., 2007). During embryonic development, transient
and highly migratory neural crest stem cells (NCSCs)
give rise to melanocytes, neurons and glial cells of PNS,
as well as connective tissue cells, chondrocytes, osteo-
cytes, and adipocytes of the craniofacial complex (Le
Douarin and Dupin, 2003). Neural crest cells share the
same developmental origin of gastrula ectoderm as the
neuroectoderm and hold multipotency yielding cells of
mesodermal and ectodermal lineages that comprise the
PNS (Knecht and Bronner-Fraser, 2002); therefore, we
hypothesized that neural rosette cultures could be hetero-
geneous and may contain NCSCs that may cause meso-
dermal tumor growth and introduce unwanted cell
populations (e.g., pigmented cells) after transplantation
into the CNS.
In examining the heterogeneity of neural rosettes,
we identified a subset (21%) of PSA-NCAM cells.Cell Reports j Vol. 4 j 821–834 j May 12, 2015 j ª2015 The Authors 821
Figure 1. PSA-NCAM-Targeted Cell Sort-
ing Can Isolate Neural Crest-like Cells
from Heterogeneous Neural Rosette
Cultures
(A) Timeline of neural rosette generation
method.
(B and C) SOX2+/NESTIN+ and SOX1+/PAX6+
neuroepithelial cells were observed in the
expanded neural rosette cultures.
(D and E) Coexpression of SOX1/ZO-1 and
PLZF/ZO-1 identified the physical property
of neural rosettes.
(F) Predominant PSA-NCAM+ expression
within the neural rosette population that
was comprised of PAX6+ neuroepithelial
cells.
(G) p75+ cells were observed peripheral to
the PSA-NCAM+ neural rosette core.
(H) AP2+/SOX1 cells were observed pe-
ripheral to the SOX1+ neural rosette core.
(I) AP2+ cells were identified at a single-cell
level.
(J and K) PSA-NCAM+ cells showed neural
rosette morphologies, whereas negative
cells exhibited neural crest-like physical
characteristics.
(L) Among the neural rosette cultures, the
populations that were positive and negative
for PSA-NCAM comprised 79% and 21%
(n = 4 independent experiments), respec-
tively. Another common method for neural
induction using Noggin and SB431542
yielded 30% PSA-NCAM cells (n = 4 in-
dependent experiments).
See also Figure S1.Interestingly, these cells did not express an early marker of
neuroectoderm (Pax6), but they possessed NCSC charac-
teristics. When isolated from neural rosette populations,
PSA-NCAM cells showed pronounced multipotent phe-
notypes when directed to differentiate. Because PSA-
NCAM cells carry multipotency of NCSCs, we postulated
that PSA-NCAM cells were responsible for the formation
of mesodermal tumors and unwanted grafts after hPSC-
derived NPC transplantation. To test the hypothesis, we
transplanted PSA-NCAM cells mixed with PSA-NCAM+
cells in a gradient manner in the rat brain. Our investiga-
tion revealed a proportional increase in mesodermal tu-
mor formation, the appearance of pigmented cells, and
PERIPHERIN+ grafts in the brain. These results indicate
that NCSCs classified as PSA-NCAM cells can be a new
target for tumor prevention in hPSC-derived-NPC-based
therapy and that removal of PSA-NCAM cells would
prevent the introduction of mesodermal tumor and
unwanted graft formations after NPC transplantation in
the CNS.822 Stem Cell Reports j Vol. 4 j 821–834 j May 12, 2015 j ª2015 The AuthoRESULTS
PSA-NCAM-Targeted Cell Sorting Isolates Neural
Crest-like Cells from Heterogeneous Neural Rosette
Populations
Neural induction and neural rosette isolation from hPSCs
were performed as described in our previous reports (Fig-
ure 1A) (Kim et al., 2010, 2012). The expanded neural
rosette cultures expressed neuroectodermal and neuroepi-
thelial markers, including sex-determining region Y-box 2
(SOX2), NESTIN, SOX1, and paired box protein 6 (PAX6)
(Figures 1B–1D). Tight junction protein (ZO-1) and pro-
myelocytic leukemia zinc finger (PLZF) expression
confirmed the neural rosette characteristics (Figures 1D
and 1E), and the previously defined ‘‘rosette-specific
markers’’ were alsomaintained throughout expansion (Fig-
ure S1A) (Elkabetz et al., 2008). As previously described, the
neural rosette cultures appeared to be mainly PSA-NCAM+
and consisted of PAX6+ neuroepithelial cells (Figure 1F)
(Kim et al., 2012). Despite the predominant PSA-NCAM+rs
expression within the cultures, negative cells were ob-
served around the outer boundary of PSA-NCAM+ rosette
core, and these cells expressed the neural crest marker
p75 (Figure 1G). Expression of AP2 (a neural crest lineage
marker) was also observed in SOX1 cells scattered around
SOX1+/AP2 neural rosettes (Figure 1H). AP2+ cells re-
mained when the neural rosette cultures were dissociated
into single cells to examine the characteristics of individual
cells (Figure 1I). These results indicated that the neural
rosette cells were heterogeneous in terms of having neural
crest-like characteristics and could be divided into PSA-
NCAM+ and PSA-NCAM populations.
The heterogeneous neural rosette cultures were divided
into two different populations via magnetic-activated cell
sorting (MACS) using PSA-NCAMantibodies. The potential
presence of residual undifferentiated cells was examined
prior toMACS; however, no PSCs were detected in the neu-
ral rosette population or the sorted cells (Figures S1B and
S1C). PSA-NCAM+ cells had the physical appearance of
polarized neural rosette cells and made of 79% of the total
neural rosette population, whereas PSA-NCAM cells had
the morphology of neural crest-like cells and account
for the remaining 21% of the total population (n = 4; Fig-
ures 1J–1L). The percentage of culture population suggests
that expanded neural rosette cultures contain approxi-
mately 21% PSA-NCAM cells with a non-neural rosette
appearance.
Molecular Characterization and Global Gene
Expression Analysis of PSA-NCAM Show NCSC
Characteristics
We analyzed the composition of PSA-NCAM cells more
closely because they exhibit a neural crest-like cell
morphology that is not observed in neural cells of the
CNS. We first examined the percentage of cells from the
neural crest lineage using three neural crest markers: p75,
HNK1, and AP2. Flow cytometry showed that up to
95.8% (n = 4) of the PSA-NCAM population was p75+,
whereas 96.8% of this population was HNK1+ (Figures 2A
and 2B). PSA-NCAM cells derived from the human
induced PSC (iPSC) line WT-iPSCEpi3 provided similar re-
sults (Figures S2A–S2D). According to the fluorescence-acti-
vated cell sorting (FACS) results, the pluripotent cellmarker
SSEA4 was not expressed in PSA-NCAM cells (Figure 2C).
Additionally, 86.9% of the initial passage (p0) of PSA-
NCAM cells were positive for AP2, and this increased to
92.3% as the cells were further subcultured (p2), suggesting
progressive specification toward neural crest cells (n = 3, p <
0.05). The quantification of cells expressing Ki67, a cell-
cycle marker for an all-active phase, showed that 88.9%
of AP2+ PSA-NCAM cells were in a proliferative state (Fig-
ure 2D). Immunocytochemical analysis of the PSA-NCAM
cells verified their neural crest identities (Figures 2E–2H). ToStemfurther characterize the PSA-NCAM cells, we performed
real-time RT-PCR analysis targeting key transcripts related
to neural crest identity. PSA-NCAM cells showed elevated
levels of p75 and AP2 compared with neural rosette cells
and PSA-NCAM+ cells (Figures S3A and S3B). The expres-
sion level of cMYC, an important factor for pluripotency
and the earliest expressed neural crest specifier (Prasad
et al., 2012), was consistent throughout the targeted cells,
with the exception of PSA-NCAM+ cells (Figure S3C). PSA-
NCAM cells displayed elevated levels of transcripts
responsible for premigratory andmigratory NCSCs (Figures
S3D–S3H), and the levels of epithelial-mesenchymal transi-
tion (EMT) regulatory factors such as TWIST1, SLUG, and
SNAIL increased with the passage number (p2 versus p4)
(Figures S3D–S3F) (Prasad et al., 2012). These results pro-
vide molecular evidence that multiple neural crest marker
genes are predominantly expressed in PSA-NCAM cells
compared with PSA-NCAM+ cells.
When isolating NCSCs from hPSCs in vitro, p75+ or
p75+/HNK1+ cells were targeted from differentiated cul-
tures as described in previous reports (Chimge and Bayar-
saihan, 2010; Jiang et al., 2009; Kreitzer et al., 2013; Lee
et al., 2007; Menendez et al., 2011). Because we are
providing the first evidence that PSA-NCAM cells are
NCSCs, we compared PSA-NCAM cells to the previously
established NCSCs, p75+/HNK1+ cells. Two step-MACS
sorting was performed to obtain p75+/HNK1+ cells, and
their purity was confirmedwith flow cytometry and immu-
nocytochemistry (Figures 2I–2L). Transcriptome analyses
were performed in triplicate to compare the global gene
expression patterns of neural rosettes, PSA-NCAM+, PSA-
NCAM, and p75+/HNK1+ cells (Figures 2M–2R). Hierarchi-
cal clustering analysis of 20,287 (fail count < 6) normalized
geneswas performed using complete linkage and Euclidean
distance asmeasures of similarity. The expressed transcripts
were clustered into two expression groups of neural rosettes
and PSA-NCAM+ cells versus PSA-NCAM cells and p75+/
HNK1+ cells (Figure 2M).
Next, we identified genes upregulated in PSA-NCAM+,
PSA-NCAM, and p75+/HNK1+ cells relative to neural ro-
settes (fold change >2.0). As shown in the Venn diagrams
in Figure 2N, 1 gene in the PSA-NCAM+ group, 104 genes
in the PSA-NCAM group, 67 genes in the p75+/HNK1+
group, and 143 genes in both the PSA-NCAM group and
the p75+/HNK1+ group were expressed at higher levels
than in the neural rosette group (Table S1). Furthermore,
we identified genes that were upregulated in PSA-NCAM
and p75+/HNK1+ cells relative to PSA-NCAM+ cells (fold
change >2.0). We found 113 genes in the PSA-NCAM
group, 56 genes in the p75+/HNK1+ group, and 144 genes
in both the PSA-NCAM and p75+/HNK1+ groups that
were upregulated compared to the PSA-NCAM+ group (Fig-
ure 2O). Gene Ontology (GO) analysis of the 257 genesCell Reports j Vol. 4 j 821–834 j May 12, 2015 j ª2015 The Authors 823
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activated in PSA-NCAM cells and 200 genes activated in
p75+/HNK1+ cells identified a number of skeletal system-
associated, neural tube-associated, mesenchyme-associ-
ated, and neural crest cell-associated terms (Tables 1, 2,
S2, and S3). GO analysis also indicated that PSA-NCAM
and p75+/HNK1+ cells were more likely to undergo EMT
in comparison to PSA-NCAM+ cells (Tables S2 and S3).
The scatter plots also showed that PSA-NCAM and p75+/
HNK1+ cells were themost similar of all the groups (Figures
2P–2R). In summary, the global gene expression profiles of
PSA-NCAM and p75+/HNK1+ cells revealed analogous
molecular characteristics between the two groups in a com-
parison to PSA-NCAM+, further confirming the authen-
ticity of the NCSC characteristics of PSA-NCAN cells.
Removal of PSA from PSA-NCAM+ Cells or
Low-Density Culture of PSA-NCAM+ Cells Leads to
Increased Neural Crest Cell Marker Expression
Our data demonstrate that PSA-NCAM cells from neural
rosette cultures are highly positive for neural crest markers.
Although previous studies have taken advantage of PSA-
NCAM expression to enrich NPCs or identify neuronal
cells, they did not acknowledge the relationship between
PSA-NCAM expression and the neural crest lineage of cells
(Barral et al., 2013; Doi et al., 2012; Glaser et al., 2007; Kim
et al., 2014). Based on a report suggesting PSA-NCAM
involvement in the regulation of p75 gene expression
in subventricular zone-derived neurons (Gascon et al.,
2007), we sought to examine the relationship between
PSA-NCAM and p75+ neural crest cell generation. We did
not find any p75+ neural crest cells in the PSA-NCAM+
cell population (Figure S4A). However, unlike the glycerol
control condition, p75+ cells appeared after PSA-NCAM+
cells were treated with endoneuraminidase-N (EndoN), anFigure 2. Molecular Characterization of PSA-NCAM Cells and Glob
HNK1+ Cells
(A and B) Flow cytometry analysis targeting p75 and HNK1 in PSA-
different PSA-NCAM cultures (n = 4).
(C) No SSEA4+ cells were observed in PSA-NCAM cells. The plot sh
cultures (n = 3).
(D) Within the PSA-NCAM culture, 86.9% of unpassaged cells (p0) w
passaged (p2); 88.9% of AP2+ PSA-NCAM cells were Ki67+ (*p < 0
experiments).
(E–H) Immunocytochemistry analysis of PSA-NCAM cells showed str
(I–L) Validation of two step-MACS isolated p75+/HNK1+ cells via flow
(M) Hierarchical clustering of the 20,287 genes was performed using
group (fail count < 6).
(N) Venn diagram of genes upregulated in PSA-NCAM+, PSA-NCAM, an
NCAM+; PN, PSA-NCAM; and NR, neural rosettes).
(O) Genes with increased expression in the PSA-NCAM and p75+/HNK1
a Venn diagram.
(P–R) Scatter plots were drawn identifying r2 values for each compar
See also Figures S2 and S3 and Table S1.
Stemenzyme that specifically removes PSA from NCAM (Figures
S4A–S4F). Conversely, treatment of PSA-NCAM cells with
either glycerol or EndoN did not alter the number of p75+
cells (Figures S4G–S4L). Real-time RT-PCR analysis further
confirmed that treatment of PSA-NCAM+ cells with EndoN
upregulated p75 gene expression but did not enhance
transcription of ST8SIA2 and ST8SIA4 genes encoding pol-
ysialyltransferases that are responsible for NCAMpolysialy-
lation (Figures S4M and S4N). Although removing PSA
from PSA-NCAM+ cells increased p75 expression, it did
not affect the neural crest cell lineage-commitment pro-
cess, showing no significant differences in the expression
levels of other NCSC-related genes (Figure S4O). These re-
sults may suggest that any observed increase of p75 expres-
sion in PSA-NCAM+ cells after PSA removal was not due to
NCSC lineage commitment; rather, the PSA moiety of the
PSA-NCAM protein negatively regulated p75 gene expres-
sion, causing a lack of p75+ neural crest cells in the PSA-
NCAM+ cell population. Thus, our data suggest an inverse
relationship between PSA-NCAM and p75 during the neu-
ral induction process, thereby explaining why only PSA-
NCAM cells are highly positive for p75.
We also continued our investigation to determine
whether that prolonged culture of positive or negative
population leads to gradual accumulation or depletion
of the NCSC population. Upon prolonged passaging of
PSA-NCAM cells, we did not observe morphological
changes indicating the presence of neuroepithelial cells
in the culture population (data not shown). However,
we have noted the appearance of cells that resemble
PSA-NCAM cells in the positive culture population and
noticed that the rate of NCSCs appearance increased
based on the degree of confluence. Thus, we speculated
that a cell density-dependent regulation might occur inal Gene Expression Pattern Analysis for PSA-NCAM+/ and p75+/
NCAM cells. Plots shown are representative of results from three
own is representative of results from three different PSA-NCAM
ere AP2+, and the positivity increased to 92.3% as the cells were
.05, unpaired Student’s t test, mean ± SEM, n = 3 independent
ong expression of p75, HNK1, and AP2 with Ki67 activity.
cytometry (95.9%) and immunocytochemistry analysis.
the mean signal intensities of three biological replicates for each
d p75+/HNK1+ groups relative to the neural rosette group (PN+, PSA-
+ groups in a comparison to PSA-NCAM+ group were compared using
ison.
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Table 1. Gene Ontology Analysis of 257 Genes Upregulated in
PSA-NCAM Cells Relative to PSA-NCAM+ Cells
GO Accession
Number GO Term
Corrected
p Value
GO: 0008284 positive regulation of cell proliferation 1.84E-08
GO: 0042127 regulation of cell proliferation 3.88E-08
GO: 0001501 skeletal system development 2.30E-07
GO: 0048705 skeletal system morphogenesis 7.02E-06
GO: 0048754 branching morphogenesis of a tube 1.11E-05
GO: 0035295 tube development 6.10E-05
GO: 0035239 tube morphogenesis 1.31E-04
GO: 0048706 embryonic skeletal system development 2.16E-03
GO: 0060562 epithelial tube morphogenesis 8.11E-03
GO: 0060348 bone development 1.54E-02
GO: 0002053 positive regulation of mesenchymal cell
proliferation
1.68E-02
GO: 0010464 regulation of mesenchymal cell
proliferation
1.88E-02
GO: 0048701 embryonic cranial skeleton morphogenesis 1.88E-02
GO: 0048762 mesenchymal cell differentiation 2.23E-02
GO: 0014031 mesenchymal cell development 2.23E-02
GO: 0060485 mesenchyme development 2.35E-02
GO: 0051216 cartilage development 5.73E-02
GO: 0014032 neural crest cell development 5.78E-02
GO: 0014033 neural crest cell differentiation 5.78E-02
See also Table S2.
Table 2. Gene Ontology Analysis of 200 Genes Upregulated in
p75+/HNK1+ Cells Relative to PSA-NCAM+ Cells
GO Accession
Number GO Term
Corrected
p Value
GO: 0001501 skeletal system development 2.60E-10
GO: 0007389 pattern specification process 4.97E-08
GO: 0035295 tube development 2.29E-07
GO: 0035239 tube morphogenesis 4.42E-07
GO: 0042127 regulation of cell proliferation 5.40E-07
GO: 0048706 embryonic skeletal system development 7.94E-07
GO: 0008284 positive regulation of cell proliferation 1.23E-05
GO: 0048705 skeletal system morphogenesis 1.35E-05
GO: 0060485 mesenchyme development 1.47E-04
GO: 0048704 embryonic skeletal system morphogenesis 2.29E-04
GO: 0060562 epithelial tube morphogenesis 4.88E-04
GO: 0014031 mesenchymal cell development 1.52E-03
GO: 0048762 mesenchymal cell differentiation 1.52E-03
GO: 0014033 neural crest cell differentiation 4.00E-03
GO: 0014032 neural crest cell development 4.00E-03
GO: 0001843 neural tube closure 3.44E-02
GO: 0060606 tube closure 3.44E-02
GO: 0051216 cartilage development 3.56E-02
GO: 0014020 primary neural tube formation 4.10E-02
GO: 0001841 neural tube formation 5.79E-02
See also Table S3.the PSA-NCAM+ culture system. To investigate this
further, we examined transcriptional changes of PSA-
NCAM+ cells (passages 4–8) in different density popula-
tions (cells/cm2). Notably, expression levels of neural
rosette-specific markers such as PLZF and DASH1, as well
as neuroepithelial markers such as PAX6 and SOX1,
showed significant decreases in the lowest density of
PSA-NCAM+ cells (Figures S5A–S5D). Conversely, neural
crest cell markers such as AP2 and p75 showed significant
increases in the lowest density (Figures S5E and S5F). At a
high density of PSA-NCAM+ cells, 2.5 3 106 cells/cm2,
only SOX1+ cells were observed with no appearance of
AP2+ cells. However, at a lowest density of PSA-NCAM+
cells, 1.0 3 106 cells/cm2, scattered AP2+ cells were noted
around SOX1+ cells (Figure S5G). These data demonstrate
that prolonged passaging of PSA-NCAM+ cells at a high
density is required to maintain neuroepithelial cell purity826 Stem Cell Reports j Vol. 4 j 821–834 j May 12, 2015 j ª2015 The Authowhile minimizing the possible appearance of PSA-NCAM
cells.
PSA-NCAM Cells Possess the Multilineage
Differentiation Capacity of NCSCs
The neural crest is amultipotent population that originates
from the dorsal region of the neural tube. NCSCs are multi-
potent and can differentiate into both ectodermal and
mesodermal tissue lineages (Le Douarin and Dupin,
2003). To characterize the in vitro functionality of PSA-
NCAM cells, we promoted the differentiation of PSA-
NCAM cells into cells with a neural crest origin (Chimge
and Bayarsaihan, 2010). Prior to inducing the multilineage
differentiation of PSA-NCAM cells, we ensured that there
were no contaminating endodermal ormesodermal lineage
cells. Neuroectoderm specified embryoid bodies (EBs)
showed no contamination of endodermal andmesodermalrs
lineage cells prior to the PSA-NCAM-targeted sorting (Fig-
ures S6A and S6B). Thus, PSA-NCAM-derivedmesodermal
lineage cells during multilineage differentiation are solely
dependent on PSA-NCAM cell potency.
To examine whether PSA-NCAM cells have the capacity
to produce mesenchymal progenitors (MPs) mimicking
neural crest development in vertebrates (Gammill and
Bronner-Fraser, 2003; Sauka-Spengler and Bronner-Fraser,
2008; Theveneau and Mayor, 2012), we spontaneously
differentiated the PSA-NCAM cells by adding 10% fetal
bovine serum (FBS) to the growth medium. Morphological
changes were observed from day 4, and MPs appeared at
day 14 (Figures 3A and 3B). Flow cytometry analysis at
day 20 revealed the loss of p75 positivity in PSA-NCAM
cell-derived MPs, whereas mesenchymal markers such as
CD44, CD29, CD73, CD105, and CD90 were detected
(Figure 3C). To compare the ability to differentiate into
mesenchymal lineages between PSA-NCAM cells and
p75+/HNK1+ cells, we performed real-time RT-PCR analysis
targeting EMT markers such as SNAIL, SLUG, TWIST1,
and VIMENTIN, as well as mesenchymal markers such
as CD29, CD44, CD73, CD90, CD105, and PDGFRa.
When the expression levels of both cell types exposed to
10% FBS were compared every 4 days for up to 32 days,
no significant differences were observed (Figure S7A). The
data suggest that both types of cells are capable of dif-
ferentiating into MPs. PSA-NCAM+ cells, on the other
hand, failed to differentiate into mesenchymal lineages
showing no significant increase in the expression levels
of either EMT or mesenchymal markers but showed a
decrease in cell viability when exposed to 10% FBS (Figures
S7B–S7F).
We also determined that the MPs differentiated from
PSA-NCAM cells retained chondrogenic, osteogenic, and
adipogenic differentiation potentials (Figures 3D–3F). The
multipotency of NCSCs also includes differentiation
into neurons that comprise the PNS. Late-passaged PSA-
NCAM cells (p6-p8) were induced to differentiate into
PERIPHERIN+ neurons via neuronal induction (Lee et al.,
2010). NESTIN+ PSA-NCAM cells slowly lost their neural
precursor characteristics and differentiated into TuJ1+
neuronal cells (Figure 3G). PERIPHERIN+ and TuJ1+ PNS
neurons were obtained on day 14 (Figure 3H). Finally,
PSA-NCAM cells could also differentiate into smooth
muscle actin a (SMAa) and CALPONIN+ smooth muscle
cells (Figures 3I and 3J), further demonstrating the multi-
potentiality of PSA-NCAM cells in vitro. Acquisition of
mesenchymal features was also observed in iPSC-derived
PSA-NCAM cells (Figure S8A), and these cells could also
differentiate into SMAa+ and CALPONIN+ cells (Figures
S8B and S8C). Similar to bona fide neural crest cells in vivo,
our data confirmed the multipotent behavior of PSA-
NCAM cells.StemTumors of Mesodermal Lineage, Pigmented Cells, and
PERIPHERIN+ Grafts Derived from PSA-NCAM Cells
To characterize the cellular behavior of heterogeneous
neural rosettes in vivo, we performed transplantations in
adult rat brains. At 10 weeks post-transplantation, we
observed rosette-rich neural overgrowth (Figures 4A–4C)
and non-neuroectodermal origin grafts (Cocchia et al.,
1983) such as a runt-related transcription factor 2
(RUNX2)+ structure (Figures 4D and 4E). Rosette-forming
neural overgrowth was identified in all transplanted ani-
mals (n = 8), while non-neuroectodermal structures with
mesodermal lineages (referred to here as tumors) were
developed in all but one of the animals (n = 7 of 8, 88%)
(Figure 4F).
Previous studies that reported tumor formation fol-
lowing cell engraftment (Arnhold et al., 2004; Doi et al.,
2012; Kim et al., 2012; Seminatore et al., 2010) and the
fact that melanocytes, chondrocytes, and smooth muscle
cells could be derived fromNCSCs prompted us to examine
whether PSA-NCAM cells play a tumorigenic role when
neural rosettes are used as a transplantation material.
PSA-NCAM cells were mixed with PSA-NCAM+ cells at
specific ratios and transplanted into the rat brain as
follows: 100% PSA-NCAM cells, 75% PSA-NCAM cells/
25% PSA-NCAM+ cells, 25% PSA-NCAM cells/75% PSA-
NCAM+ cells, and 100% PSA-NCAM+ cells. Overall, 82%,
75%, and 57% of rats grafted with 100%, 75%, and 25%
PSA-NCAM cells developed tumors, respectively (Fig-
ure 4G). In contrast, neither tumor formation nor neural
overgrowth was detected in animals grafted with 100%
PSA-NCAM+ cells. The grafts formed by the PSA-NCAM
cells also contained PERIPHERIN+ cells and showed
pigmentation as well as cyst formation (Figures 4H and
4I). Identified tumors were consisted of mesodermal line-
age derivatives, such as RUNX2-expressing bone and
SMAa-expressing smooth muscle tissues (Figures 4J and
4K). Representative H&E staining of rat brains revealed
various mesodermal lineages but showed no endodermal
lineage grafting (Figure 4L). While the 100% PSA-NCAM+
cell grafts showed no sign of neural overgrowth or tumor
formation (Figure 4M), the groups with PSA-NCAM cells
included in the grafts showed smooth muscle tissue, cyst
formation, pigmentation, and prechondrogenic tissue (Fig-
ures 4N–4Q).DISCUSSION
In this study, we analyzed the cause of mesodermal tumor
development after CNS transplantation of neural rosette-
NPCs. Our results demonstrate that the multipotent
characteristics of NCSCs among the neural rosette popula-
tions are responsible for mesodermal tumor formation,Cell Reports j Vol. 4 j 821–834 j May 12, 2015 j ª2015 The Authors 827
Figure 3. PSA-NCAM Cells Can Be Induced to Differentiate into Multilineages of NCSCs
(A and B) Bright-field images of MPs differentiated from PSA-NCAM (at d4 and d14).
(C) Loss of p75+ expression in PSA-NCAM cell-derived MPs. We also detected strong expression of mesenchymal cell markers, including
CD44, CD29, CD73, CD105, and CD90. Plots shown are representative of results from three different PSA-NCAM-derived MP cultures (n = 3).
(D–F) Generated MPs were further differentiated into the mesenchymal lineages including, Alcian blue-stained chondrocytes (D), Alizarin
red-stained osteocytes (E), and Oil red O-stained adipocytes with oil droplets (red) (F).
(G and H) PSA-NCAM cells were induced to differentiate into PERIPHERIN+ neuronal cells. NESTIN+ PSA-NCAM cells were slowly lost but
gained TuJ1 and PERIPHERIN positivity.
(I and J) SMAa+ and CALPONIN+ smooth muscle cells were also obtained.
See also Figures S6–S8.PERIPHERIN+ grafts, and the presence of pigmented cells.
Thus, identifying surface markers such as PSA-NCAM
that could distinguish betweenNPCswith CNS characteris-828 Stem Cell Reports j Vol. 4 j 821–834 j May 12, 2015 j ª2015 The Authotics and NCSCs from neural rosette cell culture popula-
tions could reduce the tumorigenic potential of hPSC-
derived NPCs.rs
We previously demonstrated that targeting PSA-NCAM+
cells via MACS from neural rosettes obtained through
dual-SMAD inhibition-induced neuralization could enrich
NPCs up to 85% SOX1+ cells (Kim et al., 2012).When these
PSA-NCAM+ sorted cells were further analyzed with FACS
to confirm the MACS results, 93% of cells were PSA-
NCAM+.Meanwhile, our current study involved the expan-
sion of neural rosettes obtained through the same method
to produce a large number of cells for in vivo transplanta-
tion. According to our data (n = 4), the total neural rosette
culture population after 7 days of expansion was 79% PSA-
NCAM+ cells and 21% PSA-NCAM cells (Figure 1L).
Despite efforts to increase the efficiency of neural induc-
tion to achieve full neural conversion of hPSCs, the cur-
rent dual-SMAD inhibition-induced neuralization method
yields >80% PAX6+ and 82% HES5+ cells (Chambers et al.,
2009) with >90% of total colonies containing neural ro-
settes (Kim et al., 2010). Although the ultimate goal would
be to prevent NCSC development during the neural induc-
tion of hPSCs, this is challenging since NCSCs and SOX1+/
PAX6+ neuroepithelial cells share the same major develop-
mental signals, including bone morphogenetic proteins
(BMPs), Wnt, fibroblast growth factor (FGF), and Notch
signaling pathways (Basch and Bronner-Fraser, 2006). As
a result, an elaborate differentiation method was required
to increase the purity of SOX1+/PAX6+ neuroepithelial cells
while suppressing NCSC development. The first approach
was employed in a previous study and achieved a decrease
of p75+ cells after treatment with FGF and BMP antagonists
(Lee et al., 2007). Although it may be possible to obtain
>80% SOX1+/PAX6+ neuroepithelial cells via the initial
isolation of neural rosettes, wewould expect that the purity
inevitably decreases during expansion to produce a large
number of cells without any targeted cell sorting or antag-
onist treatment. Based on this information, we have
concluded that 21% PSA-NCAM cells in the neural rosette
culture population was a reasonable proportion.
PSA-NCAM-targeted cell sorting from neural rosettes
allowed an isolation of NCSC populations. Compared to
the previously defined hPSC-derived NCSCs, p75+/HNK1+
cells, PSA-NCAM cells exhibited similar molecular charac-
teristics and multipotentiality; i.e., both were able to
generate ectodermal and mesodermal lineages. We also
identified an inverse relationship between PSA from
NCAM and p75 in PSA-NCAM+ cells. Removal of PSA
from PSA-NCAM+ cells with EndoN led to increased expres-
sion of the neural crest marker, p75, which explains enrich-
ment of p75+ cells in PSA-NCAM populations (Figure S4).
Though removing PSA from PSA-NCAM+ cells showed no
significant differences in the expression levels of NCSC-
related genes other than p75, a hasty conclusion should
not be made to exclude a possible role of PSA in NCSC line-
age determination. Since our study targeted the removal ofStemexisting PSA from PSA-NCAM+ cells in a short period of
time, a loss-of-function study that acquires insights of pro-
tein function should be further considered to determine a
role of PSA in NCSC lineage determination during the neu-
ral induction process.
Subsequent to PSA-NCAM-targeted cell sorting, in order
to benefit from highly enriched PSA-NCAM+ NPCs while
shielded from PSA-NCAM NCSCs, it is important to un-
derstand whether gradual accumulation or depletion of
PSA-NCAMNCSCs occurs in the PSA-NCAM+ culture pop-
ulation upon prolonged passaging. We determined that a
cell density-dependent regulation took place in the PSA-
NCAM+ culture system and the rate of NCSC appearance
increased when the degree of confluence of positive cells
decreased (Figure S5). Our data demonstrate that prolonged
passaging of PSA-NCAM+ cells at a high density is required
to maintain neuroepithelial cell purity while minimizing
the possible appearance of PSA-NCAM cells. Although it
has been determined that NCSCs originate from the border
of neural and epidermal ectoderm based on ‘‘a long-stand-
ing interpretation’’ of developmental studies, it is still not
clear whether NCSCs are induced or self-differentiated. If
NCSCs are induced hypothetically, questions still remain
whether their induction separates from, is part of, or occurs
subsequent to the neural induction process of embryo
(Hall, 2009). Thus, we cannot yet conclude whether ap-
peared PSA-NCAM cells in a low density of PSA-NCAM+
cells were self-differentiated or induced from PSA-NCAM+
cells at this point.
Previous studies targeted remaining PSCs in cell cultures
in attempts to deplete tumor-initiating cells (Ben-David
and Benvenisty, 2014; Tang et al., 2011).While such strate-
gies were successful in removing PSCs, targeting PSCs alone
was insufficient to completely eliminate tumorigenic po-
tential of NPCs. Notably, our data indicate that isolated
PSA-NCAM cells play a significant role in mesodermal
tumor development in the adult rat brain. The detection
of mesodermal derivatives, PERIPHERIN+ cells, and pig-
mented tissues in grafts of PSA-NCAM cells suggested
that tumorigenesis after neural rosette engraftment was
caused by NCSCs that comprise the PSA-NCAM cell pop-
ulation. Our results demonstrate that PSA-NCAM NCSCs
can be a critical target for tumor prevention in hPSC-
derived-NPC-based therapy and suggest that removal of
PSA-NCAM cells would completely eliminate the tumori-
genic potential originating from NCSCs following trans-
plantation of NPCs into the CNS.EXPERIMENTAL PROCEDURES
Stem Cell Culture and Differentiation
Undifferentiated hESCs (H9 [WA09; WiCell]) were cultured on
mouse SIM Thioguanine/Ouabain-resistant mouse fibroblast cellCell Reports j Vol. 4 j 821–834 j May 12, 2015 j ª2015 The Authors 829
Figure 4. Tumors of Mesodermal Lineage and PERIPHERIN+ Grafts Can Be Derived from PSA-NCAM Cells
(A–C) Representative H&E-stained neural rosette graft showing neural overgrowth.
(D and E) Structures of non-neuroectodermal origin such as RUNX2+ graft.
(F) Neural overgrowth and tumor formation detected at rates of 100% and 88%, respectively, from neural rosette grafts.
(G) Summary of tumor formation and cell lineages derived from PSA-NCAM+/ grafts. Regardless of tumor formation, lineages were
identified based on apparent phenotypes. Fractional numbers represent the number of rats identified with tumors or grafted cell lineages
(legend continued on next page)
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line (STO) fibroblasts (ATCC) under previously described growth
conditions (Jang et al., 2011). For induction of neural rosettes,
EBs were cultured in suspension for 4 days in hESC media
excluding basic FGF (bFGF) but supplemented with 5-mM dorso-
morphin (DM) (Calbiochem) and 5- to 10-mM SB431542 (SB)
(Sigma). On day 4, EBs were attached in Matrigel-coated culture
dishes (BD Biosciences) in DMEM/F12 N2 supplemented media
(N2 media) with 20-ng/ml bFGF (R&D Systems) and 19- to
21-mg/ml human insulin solution (Sigma-Aldrich) for another
5 days. The emerged rosette structures were mechanically isolated
using pulled glass pipettes within the EB colonies, and isolated
neural rosette clumps were replated in Matrigel-coated dishes. Re-
plated neural rosettes were then expanded for an additional 6 to
7 days at 90% confluence. PSA-NCAM+ and PSA-NCAM cells
were isolated via MACS (Miltenyi Biotec) as previously described
(Kim et al., 2012). Isolated cells were plated in Matrigel-coated
dishes at a density of 1–1.55 3 105 and 1–1.25 3 105 cells/cm2
for PSA-NCAM+ and PSA-NCAM cells, respectively. Although
PSA-NCAM cells were maintained in N2 media with insulin,
20-ng/ml bFGF, and 10-ng/ml epidermal growth factor (EGF)
(Peprotech), the positive cells were maintained in DMEM/F12 N2
and B27 without vitamin A-supplemented media (N2B27 media)
with 20-ng/ml bFGF. Media were replaced daily. For isolation of
NCSCs from the propagated neural rosette population, additional
two-step MACS (CD271; CD57 MicroBeads, Miltenyi Biotec) was
performed following the same procedures with a slight modifica-
tion. Isolated CD271+ cells were washed with calcium-, magne-
sium-free, and phenol red-free HBSS (GIBCO, Life Technologies)
twice. The positive cells then eluted with 1 3 TrypLE Express
(GIBCO, Life Technologies) and nutated in TrypLE Express for
3–5 min (Lee and Lufkin, 2012). To stop the reaction, we washed
cells with 2% BSA-PBS solution followed by 13 cold PBS wash
before attachment of CD57 MicroBeads and application over a
second column. For peripheral neuron differentiation, PSA-
NCAM cells (passages 6–8) were seeded in fibronectin- or poly-L-
ornithine/laminin-coated four-well dishes in N2B27 media with
brain-derived neurotrophic factor (10 ng/ml), glial cell line-
derived neurotrophic factor (10 ng/ml), nerve growth factor
(10 ng/ml), neurotrophin-3 (10 ng/ml) (all Peprotech), ascorbic
acid (200 mM; Sigma-Aldrich), and N-[N-(3,5-Difluorophenace-out of the total number of transplanted rats. The numbers in parenthe
lineages. Transplanted neural rosettes were derived from four indepen
independent experiments, respectively.
(H) The frequencies of PERIPHERIN+, pigmented graft detection, and
identified with unwanted grafts out of the total number of transpla
identified with unwanted grafts. Transplanted neural rosettes were de
were derived from five independent experiments, respectively.
(I) HNA+/PERIPHERIN+ cells in grafts with PSA-NCAM cells.
(J) H&E staining and immunofluorescent histochemistry analysis sho
(K) SMAa+ smooth muscle tissue detected in PSA-NCAM grafts.
(L) Representative H&E-stained coronal images revealing tumors of m
unlike the 100% PSA-NCAM+ graft (top image).
(M) PSA-NCAM+ cell graft showed no sign of neural overgrowth or tum
(N) The groups with PSA-NCAM cell grafts showed smooth muscle ti
(O and P) Cyst formation and pigmentation observed in the groups w
(Q) Prechondrogenic tissue formation observed in the groups with PS
Stemtyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) (2.5mM;Calbio-
chem) (Lee et al., 2010). Differentiation was induced for 20 days
before immunocytochemistry assays were performed. For mesen-
chymal differentiation, PSA-NCAM cells were cultured in N2me-
dia for24hr and switched toDMEMGlutaMAXsupplementedwith
10% FBS and 5-mg/ml gentamicin. Adipocyte, chondrocyte, and
osteocyte differentiations were carried out according to the manu-
facturer’s instructions using StemPro Differentiation Kits (Invitro-
gen). For removal of PSA from the surfaces, EndoN (Abc Scientific),
which specifically degrades linear a-2,8-linked PSA,was introduced
to PSA-NCAM+/ cells for 24 (data not shown) or 48 hr.Immunocytochemistry and Flow Cytometry
Cells were fixed in 4% paraformaldehyde-PBS solution. For visual-
ization of intracellularmarkers, cells were permeabilizedwith 0.1%
Triton X-100-PBS solution, blocked with 2% BSA-PBS solution for
1 hr at room temperature, and incubated overnight at 4C with
primary antibodies as listed in Table S4. Appropriate fluores-
cence-tagged secondary antibodies (Molecular Probes and Vector
Laboratories) were used for visualization. Cells were mounted in
DAPI mounting medium (Vector Laboratories), and images were
obtained using an Olympus IX71 microscope equipped with a
DP71 digital camera or Olympus FSX100 system. MetaMorph
Microscopy Automation and Image Analysis Software (Molecular
Devices) were used to count positive cells in seven to ten randomly
selected images at a finalmagnification of3200 from each of three
independent experiments. For flow cytometry, cells were dissoci-
ated into single cells usingGIBCOCell Dissociation Buffer (Invitro-
gen) and incubated in 1% BSA-PBS solution with the appropriate
antibodies as listed in Table S4. For unconjugated primary anti-
bodies, the cells were incubated with Alexa-Flour 488-conjugated
anti-mouse IgG/IgM (Molecular Probes) for raising suitable second-
ary antibodies. Flow cytometry was performed using FACSCalibur
(BD Biosciences) and analyzed using WinMDI 2.8 or FACSVerse
(BD Biosciences) and FlowJo software.Gene Expression Analyses and Transcription Profiling
Total RNA was isolated using the Easy-Spin Total RNA Extraction
Kit (iNtRON). cDNA was synthesized from 1 mg of total RNA usingses refer to percentage of rats identified with tumors or grafted cell
dent experiments, while PSA-NCAM+/ cells were derived from five
cyst formation. Fractional numbers represent the number of rats
nted rats. The numbers in parentheses refer to percentage of rats
rived from four independent experiments, while PSA-NCAM+/ cells
wing RUNX2+/HNA+ bone tissue in PSA-NCAM grafts.
esodermal lineage from PSA-NCAM grafts (bottom three images)
or formation.
ssue.
ith PSA-NCAM cell grafts.
A-NCAM cell grafts.
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the PrimeScript RT Master Mix (Takara Bio). mRNA levels were
quantified by real-time RT-PCR assays using the SYBR Premix Ex
Taq (Takara Bio) and CFX96 Real-Time System (Bio-Rad). Ct values
for each targeted gene were normalized according to those of
b-actin, and the normalized expression levels of the targeted genes
were compared between the sorted/unsorted samples and control
samples based on the comparative Ct method. Data are expressed
as the mean relative expression ± SEM from three independent
experiments. Semiquantitative PCR was performed using the
EmeraldAMP GT PCR master mix (Takara Bio) in the GeneAmp
PCR System 2720 (Applied Biosystems). The sequences of the
primers used to characterize H9, neural rosettes, and PSA-
NCAM+/ cells are provided in Table S5. For microarray analysis,
10 mg of total RNA from each sample was processed and analyzed
by Macrogen, and the samples were hybridized to the Human HT-
12 Expression v.4.0 bead array. For clustering analysis, the normal-
ized data were narrowed down to 20,287 using a cutoff based on
fail count < 6. We found 1,178 out of 20,287 genes with p >
0.05 (local-pooled error test adjusted p value cutoff <0.05). GO
analyses were performed using DAVID (Database for Annotation,
Visualization and Integrated Discovery). Significantly upregulated
genes were compared against DAVID’s GO FAT database to clarify
biological meanings. The p values were derived using Fisher’s
exact tests (p < 0.01; fold enrichment R2.0), and the corrected
p values were applied to multiple testing corrections using the
Benjamini-Yekutieli method.In Vivo Transplantation and Immunohistochemistry
We used adult male Sprague-Dawley rats weighing 200–250 g at
the time of transplantation (Orient Bio). Propagated neural
rosettes (d7) and PSA-NCAM+/ cells were dissociated into single
cells using Accutase (Millipore) and then suspended in Dulbecco’s
PBS to a final cell concentration of 1 3 105 cells/ml. Three micro-
liters of the cell suspension was stereotaxically transplanted per
rat at the following coordinates: AP +0.05, ML +0.30, DV 0.40
and 0.50. Next, 30-mg/kg Zoletil (Virbac) was combined with
10-mg/kg Rompun (Bayer) for anesthesia, and 10-mg/kg cyclo-
sporine A (Chong Kun Dang) was intraperitoneally administered
24-hr pre-transplantation and every day thereafter until the rats
were sacrificed. At 10 weeks post-transplantation, the rats were
anesthetized with the anesthetic mixture (Zoletil:Rompun) and
transcardially perfused with 0.9% saline solution followed by
4% paraformaldehyde. Removed brains were post-fixed overnight
and cryoprotected in 30% sucrose-PBS solution. Cryoprotected
brains were embedded in FSC 22 compound (Leica), and serial
coronal sections were sliced at 16–20 mm using a cryostat
(Thermo Scientific). Progressive H&E staining was performed,
and immunohistochemistry was carried out as previously
described (Kim et al., 2012). Lineages of structures found in
each graft were determined based on H&E sections first, followed
by immunofluorescence staining targeting specific antigens with
appropriate antibodies as listed in Table S4. Animal research was
conducted under the supervision of the Department of Labora-
tory Animal Medicine, Medical Research Center, Yonsei
University College of Medicine and followed the guidelines of
the Institutional Animal Care and Use Committee (Permit No.
2013-0040).832 Stem Cell Reports j Vol. 4 j 821–834 j May 12, 2015 j ª2015 The AuthoStatistical Analysis
Data are shown as the mean ± SEM of at least three independent
experiments. Data were analyzed using the paired/unpaired, two-
tailed Student’s t tests or ANOVA when two or more groups were
involved.
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